Abstract：Objective To explore the effect of the clinical approach of ST-segment elevation acute coronary syndrome.Methods 120 patients weres selected as research subjects,who was in ST-segment elevation acute coronary syndrome in our hospital from January 2013 to December 2016.The patients were divided into control group and CP group according to before and after the implementation of standardized rescue,with 60 cases in each group.For the control group to take routine treatment,CP group was based on our hospital′s own STE-ACS clinical path for diagnosis and treatment.The hospitalization time,average hospitalization cost,average drug cost and satisfaction degree were choosed as an evaluation indexs.Results CP group effective rate was 95.0%higher than the control group′s 86.7%(P＜0.05).The average hospital stay was(10.97±2.11)day in the CP group and(13.32±25)day in the control group(P＜0.05).The average cost of CP group was(7224.28±106.23)yuan,and the average cost of the control group was(8319.23±16.35)yuan(P＜0.05).CP group′s satisfaction was 96.67%,control group′s satisfaction was 81.67%(P＜0.05);CP group′s adverse reaction rate was 1.67%,the control group was 6.67%(P＜0.05).Conclusion Clinical application of the clinical pathway in patients with ST-segment elevation acute coronary syndrome(STE-ACS)was expected to be satisfactory.Not only improve the quality of medical care,but also shorten the number of hospital days,reduce the cost of hospitalization,in line with China′s national conditions.CP can be better improve the quality of medical care,protect medical security,standard medical charges,save health resources,improve patient satisfaction,Can be widely used in clinical practice.
京公网安备 11010502046607号